SG11202009805PA - Methods of treating autism spectrum disorders using human umbilical cord tissue-derived mesenchymal stromal cells - Google Patents

Methods of treating autism spectrum disorders using human umbilical cord tissue-derived mesenchymal stromal cells

Info

Publication number
SG11202009805PA
SG11202009805PA SG11202009805PA SG11202009805PA SG11202009805PA SG 11202009805P A SG11202009805P A SG 11202009805PA SG 11202009805P A SG11202009805P A SG 11202009805PA SG 11202009805P A SG11202009805P A SG 11202009805PA SG 11202009805P A SG11202009805P A SG 11202009805PA
Authority
SG
Singapore
Prior art keywords
methods
umbilical cord
stromal cells
human umbilical
derived mesenchymal
Prior art date
Application number
SG11202009805PA
Inventor
Joanne Kurtzberg
Geraldine Dawson
Jessica Sun
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of SG11202009805PA publication Critical patent/SG11202009805PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Developmental Disabilities (AREA)
  • Educational Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
SG11202009805PA 2018-04-04 2019-04-04 Methods of treating autism spectrum disorders using human umbilical cord tissue-derived mesenchymal stromal cells SG11202009805PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862652722P 2018-04-04 2018-04-04
PCT/US2019/025716 WO2019195506A1 (en) 2018-04-04 2019-04-04 Methods of treating autism spectrum disorders using human umbilical cord tissue-derived mesenchymal stromal cells

Publications (1)

Publication Number Publication Date
SG11202009805PA true SG11202009805PA (en) 2020-11-27

Family

ID=68101425

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009805PA SG11202009805PA (en) 2018-04-04 2019-04-04 Methods of treating autism spectrum disorders using human umbilical cord tissue-derived mesenchymal stromal cells

Country Status (11)

Country Link
US (1) US20210128631A1 (en)
EP (1) EP3773486B1 (en)
JP (1) JP2021520380A (en)
KR (1) KR20210031853A (en)
CN (1) CN112351785A (en)
AU (1) AU2019247210A1 (en)
BR (1) BR112020020295A2 (en)
CA (1) CA3096033A1 (en)
IL (1) IL277733A (en)
SG (1) SG11202009805PA (en)
WO (1) WO2019195506A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113057969A (en) * 2021-03-09 2021-07-02 吴志新 Clinical application experiment method of mesenchymal stem cells to infantile autism

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009046377A2 (en) * 2007-10-04 2009-04-09 Medistem Laboratories, Inc. Compositions and methods of stem cell therapy for autism
WO2012082056A1 (en) * 2010-12-16 2012-06-21 Autism Biodiagnosis Ltd. Novel biomarker and uses thereof in diagnosis, treatment of autism
AU2017235446A1 (en) * 2016-03-16 2018-11-08 Cell Medicine, Inc. Mesenchymal stem cells with enhanced efficacy
US20170296588A1 (en) * 2016-04-19 2017-10-19 AngioStem, Inc. Mesenchymal stem cells derived from placental sources
JP7126703B2 (en) 2016-05-24 2022-08-29 国立大学法人 東京大学 Cerebral disorder therapeutic agent containing umbilical cord-derived cells
US10987381B2 (en) * 2017-01-27 2021-04-27 Neil Riordan Mesenchymal stem cells with enhanced efficacy in treatment of autoimmunity particularly rheumatoid arthritis

Also Published As

Publication number Publication date
AU2019247210A1 (en) 2020-11-05
KR20210031853A (en) 2021-03-23
JP2021520380A (en) 2021-08-19
EP3773486C0 (en) 2023-12-06
CN112351785A (en) 2021-02-09
WO2019195506A1 (en) 2019-10-10
US20210128631A1 (en) 2021-05-06
CA3096033A1 (en) 2019-10-10
EP3773486A1 (en) 2021-02-17
BR112020020295A2 (en) 2021-01-12
IL277733A (en) 2020-11-30
EP3773486B1 (en) 2023-12-06
EP3773486A4 (en) 2021-12-15

Similar Documents

Publication Publication Date Title
IL304429A (en) Methods and compositions for treatment of epileptic disorders
EP3388512A4 (en) Method for separating and culturing mesenchymal stem cells from wharton's jelly tissue of umbilical cord
IL283325A (en) Methods for treatment using adoptive cell therapy
HUE060671T2 (en) Methods of treatment for fibrotic diseases
ZA201702214B (en) Methods of using interleukin-10 for treating diseases and disorders
IL262989A (en) Methods of treating autoimmune disease using allogeneic t cells
MX2018012902A (en) Compositions and methods for the treatment of lysosomal storage disorders and disorders characterized by lysosomal dysfunction.
EP3197440A4 (en) Treatment of anxiety disorders and autism spectrum disorders
EP3234116A4 (en) Methods of treating tissue calcification
IL272937A (en) Compositions and methods for the treatment of fibrotic diseases
MX2017007953A (en) Treatment of retinal degeneration using progenitor cells.
EP3630101A4 (en) Methods for treatment of fibrotic diseases
EP3402477A4 (en) Methods for the treatment of myeloid derived suppressor cells related disorders
IL251616B (en) Methods and compositions for treating and preventing muscle wasting disorders
SG11202104053TA (en) Compositions and methods for the treatment of estrogen-dependent disorders
IL277733A (en) Methods of treating autism spectrum disorders using human umbilical cord tissue-derived mesenchymal stromal cells
GB202015959D0 (en) Treatment of diseases involving NAD
EP3341012A4 (en) Methods of using interleukin-10 for treating diseases and disorders
PT3589298T (en) Mesenchymal stem cells obtained from wharton's jelly for the treatment of sepsis
IL278978A (en) Compositions and methods for treatment of psoriasis
HK1245671A1 (en) Methods of using interleukin-10 for treating diseases and disorders
EP3570852A4 (en) Methods of treating multiple sclerosis using autologous t cells
IL288301A (en) Methods of culturing human pluripotent cells
IL281284A (en) Methods of treating psoriasis
EP3541371A4 (en) Methods for treatment of interstitial cystitis